ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
Recently, Novavax (NASDAQ:NVAX) fell fast. Closing at $207.31 per share on Sept. 30, the vaccine play opened at around $190 on Oct. 1. After that, NVAX stock quickly went into free fall, dropping as low as $154 per share. Source: Ascannio/Shutterstock.com The reason? Breaking news of Merck’s (NYSE:MRK) antiviral Covid-19 pill. Interim results suggest it
Download Preston’s 1 page checklist for finding great stock picks: http://buffettsbooks.com/checklist Preston Pysh is the #1 selling Amazon author of two books on Warren Buffett. The books can be found at the following location: In this lesson, students learned the importance of investing in vigilant leaders. A vigilant leader is a manager that won’t put
I’ve got a question for you. How many shares are you trading currently on per trade basis? How do you decide that? Well, there’s a lot of people out there that wonder exactly this “How many shares should they trade” Should I trade 2 percent of my account size? Or just always trade 100 shares
The “three-legged stool” is an old phrase that many financial planners once used to describe the three most common sources of retirement income: Social Security, employee pensions, and personal savings. It was expected that this trio would together provide a solid financial foundation for the senior years. None of the three was expected to support
In the Century of Biology, it pays to own the future of curing disease at the root.
Hyliion Holdings (NYSE:HYLN) has been a painful investment for many. A year ago, it shares were was trading as high as $55 a piece. Yet its been downhill ever since. I cautioned in March that a HYLN stock investment would require patience. Source: Hyliion media The stock is down nearly 50% since that call. Despite
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit
In this article ATVI DELL OTMO Dell CEO Michael Dell speaks during an interview with CNBC on the floor of the New York Stock Exchange, July 2, 2018 Brendan McDermid | Reuters The fourth quarter has just begun, and Wall Street analysts are picking out the companies they believe have potential for the long run.
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
With the seemingly worsening crisis of property developer China Evergrande (OTCMKTS:EGRNF), it may be time for investors to at least consider reducing exposure to companies tied to the world’s second-largest economy. Late last week, the Wall Street Journal reported that Evergrande failed to make a scheduled interest payment last Thursday, sparking concerns about a mass
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data
Download Preston’s 1 page checklist for finding great stock picks: http://buffettsbooks.com/checklist Preston Pysh is the #1 selling Amazon author of two books on Warren Buffett. The books can be found at the following location: In this lesson, Students learned about the fundamental aspects of preferred stock. Although Preferred shares are a proportional ownership of equity
We hear it all the time: The middle class is shrinking. Wages seem to have been stagnant for decades and American families are struggling with financial insecurity. However, what exactly is the middle class? Who is in it, and who is not? Is it shrinking? What about you? Which income class do you belong to?
You can invest in the growing space economy with these ETFs. Procure Space ETF: https://www.zacks.com/funds/etf/UFO/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Kensho Final Frontiers ETF: https://www.zacks.com/funds/etf/ROKT/profile?cid=CS-YOUTUBE-FT-VID Virgin Galatic: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Maxar Technologies: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Dish Network: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Intelsat: https://www.zacks.com/stock/quote/I?cid=CS-YOUTUBE-FT-VID Northrup Grumann: https://www.zacks.com/stock/quote/NOC?cid=CS-YOUTUBE-FT-VID Lockheed Martin: https://www.zacks.com/stock/quote/LMT?cid=CS-YOUTUBE-FT-VID
Jeff Bezos, left, and Elon Musk Getty Images; Reuters Elon Musk repeated prior criticisms of fellow billionaire space mogul Jeff Bezos, as their respective companies continue to battle in federal court and in front of regulators. “I think I’ve expressed my thoughts on that front – I think he should put more of his energy
In reviewing the opportunity in Roku (NASDAQ:ROKU) stock, I need to start with an apology. A few years ago, I harshly judged it for its delay in reaching profitability. I had good reason at the time, since after 16 years they were still losing money. Management has most definitely shut me up, though, and that’s
As seen in recent days, even meme stock legend AMC Entertainment (NYSE:AMC) is starting to see the effects of the market growing more risk-averse. Since Sept. 13, shares in AMC stock have pulled back from $51.69, down to around $35.50 per share. Source: viewimage / Shutterstock.com Unfortunately, this may be only the start of AMC’s